Hot Investor Mandate: Medical Device Arm of Large Chinese Pharma Seeks to Invest in and Support Commercialization of Early-Stage Life Science Companies

24 Oct

A medical device of a large Chinese pharmaceutical company has 226 affiliated companies with a total of over 8,000 employees, making over 3 billion revenue each year. The firm is interested in early-stage diagnostics, medical device and healthcare IT companies, but will also consider drugs in applicable cases.

The firm is generally interested in medical devices, diagnostics, and Digital healthcare companies with a preference for healthcare platform and CFDA approved companies. The firm will look at different stage companies that are investing in angel to pre-A, and IPO companies and provide investment consulting services to the firm

The firm invests globally but prefers companies with Chinese backgrounds. The firm strongly prefers companies with at least one Mandarin speaker in the management teams. The firm is willing to work with academic researchers or companies that are in very early stages and can provide supports in commercialization using the firm’s already-established internet platforms.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: